Improving sample and library QC in NGS core facilities

In the dynamic landscape of next-generation sequencing (NGS), quality control (QC) is critical in ensuring the reliability and accuracy of genomic data provided to researchers seeking core lab support. With the exponential growth of genomic research and the choice of different electrophoresis instruments for sample and library QC, how can core labs ensure they have the most robust method in place? Current gel electrophoresis methods are limiting in terms of convenience, cost and analytical insight. This warrants an advanced solution to improve NGS quality control standards while saving resources and increasing data quality.

Join us for this insightful webinar as we review:

Challenges and limitations of size and contamination analysis in NGS workflow QC
How to incorporate advanced capillary electrophoresis into NGS workflows
Benefits for the core

A live Q&A will follow the webinar.

About the speaker

Marion Egli, Senior Global Product Manager, Automated Systems

QIAGEN

Marion Egli is spearheading the QIAxcel capillary gel electrophoresis portfolio and is a passionate advocate for simple but meticulous quality control solutions. Working for QIAGEN for more than 10 years, Marion has held positions in product management, strategic marketing and service - and contributed to the launch of several instruments for molecular testing.

Tamar Vardi, Applications Lab Expert

QIAGEN

Tamar Vardi has worked in the QIAGEN Applications Lab in North America for the past 16 years and is an expert user of our LS Automation portfolio and related software. The Applications Lab is integral to customer success by supporting product demonstrations, providing training, and applying third-level technical expertise for troubleshooting and testing unique samples. She has developed various novel applications and frequently helps users of the QIAxcel capillary gel electrophoresis system, so Tamar's colleagues have nicknamed her "the QIAxcel whisperer."

Shu Boles, PhD, MBA, Director, Strategic Marketing, Genomics

QIAGEN

Shu Boles holds a PhD in developmental biology from Washington University in St. Louis and did her postdoctoral training at UC San Diego. She also holds an MBA from UC San Diego – Rady School of Management. Shu has extensive experience in next-generation sequencing in research applications, especially cancer research, and clinical oncology. In 2022, Shu joined QIAGEN as Director of Genomics Strategic Marketing.